// App-Quantinova.ai

1851 : A Phase I/II Study of Bendamustine, Low-Dose Dexamethasone, and Lenalidomide (BdL) for the Treatment of Patients with Relapsed Multiple Myeloma

Researchers

Presenter

  • Samantha Pozzi

Principal Investigators

  • Stefania Badiali

  • Giovanni Quarta

  • Antonio Lazzaro

  • Antonio Palumbo

  • Fortunato Morabito

  • Attilio Guarini

  • Carla Mazzone

  • Alessandro Corso

  • Donatella Vincelli

  • Luciano Masini

  • Pellegrino Musto

  • Roberto Ria

Medical Centers

  • Internal Medicine and Clinical Oncology, University of Bari, Bari, Italy

  • Padova, Italy

  • Dept of Hematology Oncology, Fondazione IRCCS Policlinico San Matteo & Department of Diagnostic and Clinical Medicine, and Public Health, University of Modena and Reggio Emilia, Modena, Italy

  • Division of Hematology, Perrino Hospital, Brindisi, Italy

  • Department of Hematology, Santa Maria Nuova Hospital, Reggio Emilia, Italy

  • Department of Internal Medicine, Hematology Unit, Cosenza Hospital, Cosenza, Italy

  • Hematology Unit, Bianchi-Melacrino-Morelli Hospital, Reggio Calabria, Italy

  • Department of Oncology- Hematology Unit, National Cancer Centre, Bari, Italy

  • Division of Hematology, A.O.U. San Giovanni Battista, University of Torino, Turin, Italy

  • Department of Onco-Hematology, IRCCS-CROB, Italy,

  • Division of Medical Oncology and Hematology, Piacenza Hospital, Piacenza, Italy

Locations

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

Disease

  • Renal insufficiency

  • Multiple Myeloma

  • Thrombocytopenia

  • Myocardial ischemia

  • Intracerebral hemorrhage

  • Neutropenia

  • Coronary Artery Disease

  • Anemia

Biomarkers

  • Circulating tumor cells

  • Denticleless E3 ubiquitin protein ligase homolog

Drug/Treatment

  • Dexamethasone

  • Dekpak 13 Day Taperpak

  • Bendamustine

  • Lenalidomide

  • Thalidomide

  • Bortezomib

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved